Indonesia’s Bumame raised Pre-Series A funding from Alpha JWC Ventures for expansion

The health technology company Bumame, based in Indonesia, has announced the successful conclusion of a funding round led by Alpha JWC Ventures. Kopital Ventures and 500 Global also participated.
According to a statement released by Bumame on Thursday, this expedites the company’s goal of becoming Indonesia’s premier comprehensive healthcare partner by providing proactive, preventive care to all Indonesians and enabling them to take control of their own health.
Bumame will be able to expand its healthcare offerings and speed up its digital transformation due to the new funding.
The company claimed that by emphasizing early detection, quick and precise diagnostic results, and customized health insights, it is enabling people to make well-informed decisions regarding their health.
Additionally, the investment will help create smooth, tech-driven customer experiences that showcase the business’s dedication to accessibility and innovation.
“This milestone marks the beginning of an exciting new chapter for Bumame,
“The trust we built during the pandemic laid a strong foundation, but this funding empowers us to go further,” said James Wihardja, Co-Founder and Chief Executive Officer of Bumame.
“We are not just a healthcare provider; we aspire to be a lifelong health partner for every individual in Indonesia,
“Our ultimate mission is to foster a healthier, more confident society by emphasizing proactive and preventive care,” he added.
Bumame is a full-service healthcare partner that was introduced in 2020 and provides proactive health screenings, advanced diagnostics, and individualized health advice.
The company provides a wide range of healthcare services, from advanced diagnostics and regular checkups to individualized health plans that help people live healthier lives.
Indonesia’s healthcare market was estimated to be worth $50 billion in 2024, growing at an annual rate of 11% due to the growing demand for easily accessible, modern healthcare solutions.
This quickly growing market emphasizes how important it is to have a reliable partner like Bumame to rethink healthcare affordability and accessibility for all Indonesians.
According to Bumame, the company is in a unique position to satisfy the rising demand for easily accessible, comprehensive healthcare solutions as Indonesia’s healthcare system continues to change.
The company claimed to be redefining the healthcare experience by making it more seamless, effective, and individualized through the use of state-of-the-art technology and patient-centered medical practices.
“This funding is a testament to Bumame’s bold vision and the trust it has earned from investors, partners, and communities,
“By prioritizing technology, proactive care, and high- quality products sourced from top principals with global standards, Bumame ensures that healthcare is not only accessible but also affordable for all Indonesians,” said Chandra Tjan, Co-Founder & General Partner, Alpha JWC Ventures.
Alpha JWC Ventures is a Southeast Asian venture capital firm that focuses on early to growth stages.
In 2016, the first independent and institutional early-stage venture capital fund in Indonesia was established.
With more than 80 active portfolio companies spread throughout Southeast Asia, the firm currently manages approximately $650 million in assets under management (AUM).